Mathematical model for chemotherapeutic drug efficacy in arresting tumour growth based on the cancer stem cell hypothesis

被引:35
作者
Ganguly, R.
Puri, I. K.
机构
[1] Virginia Polytech Inst & State Univ, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA
[2] Univ Jadavpur, Dept Power Engn, Kolkata 700032, W Bengal, India
关键词
D O I
10.1111/j.1365-2184.2007.00434.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: Cancer stem cells have been identified as the growth root for various malignant tumours and are thought to be responsible for cancer recurrence following treatment. Materials and methods: Here, a predictive mathematical model for the cancer stem cell hypothesis is used to understand tumour responses to chemotherapeutic drugs and judge the efficacy of treatments in arresting tumour growth. The impact of varying drug efficacies on different abnormal cell populations is investigated through the kinetics associated with their decline in response to therapy. Results and conclusions: The model predicts the clinically established 'dandelion phenomenon' and suggests that the best response to chemotherapy occurs when a drug targets abnormal stem cells. We compare continuous and periodic drug infusion. For the latter, we examine the relative importance of the drug cell-kill rate and the mean time between successive therapies, to identify the key attributes for successful treatment.
引用
收藏
页码:338 / 354
页数:17
相关论文
共 35 条
[21]   Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation [J].
Molofsky, AV ;
Pardal, R ;
Iwashita, T ;
Park, IK ;
Clarke, MF ;
Morrison, SJ .
NATURE, 2003, 425 (6961) :962-967
[22]   Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia [J].
O'Brien, SG ;
Guilhot, F ;
Larson, RA ;
Gathmann, I ;
Baccarani, M ;
Cervantes, F ;
Cornelissen, JJ ;
Fischer, T ;
Hochhaus, A ;
Hughes, T ;
Lechner, K ;
Nielsen, JL ;
Rousselot, P ;
Reiffers, J ;
Saglio, G ;
Shepherd, J ;
Simonsson, B ;
Gratwohl, A ;
Goldman, JM ;
Kantarjian, H ;
Taylor, K ;
Verhoef, G ;
Bolton, AE ;
Capdeville, R ;
Druker, BJ ;
Durrant, S ;
Schwarer, A ;
Joske, D ;
Seymour, J ;
Grigg, A ;
Ma, D ;
Arthur, C ;
Bradstock, K ;
Joshua, D ;
Louwagie, A ;
Martiat, P ;
Straetmans, N ;
Bosly, A ;
Shustik, C ;
Lipton, J ;
Forrest, D ;
Walker, I ;
Roy, DC ;
Rubinger, M ;
Bence-Bruckler, I ;
Kovacs, M ;
Turner, AR ;
Birgens, H ;
Bjerrum, O ;
Facon, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (11) :994-1004
[23]   The biology and engineering of stem-cell control [J].
O'Neill, A ;
Schaffer, DV .
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2004, 40 (01) :5-16
[24]   Getting at the root and stem of brain tumors [J].
Oliver, TG ;
Wechsler-Reya, RJ .
NEURON, 2004, 42 (06) :885-888
[25]   Applying the principles of stem-cell biology to cancer [J].
Pardal, R ;
Clarke, MF ;
Morrison, SJ .
NATURE REVIEWS CANCER, 2003, 3 (12) :895-902
[26]  
Pierce A, 2001, Hematol J, V2, P257, DOI 10.1038/sj.thj.6200114
[27]  
Polakis P, 2000, GENE DEV, V14, P1837
[28]   Roots and stems: stem cells in cancer [J].
Polyak, K ;
Hahn, WC .
NATURE MEDICINE, 2006, 12 (03) :296-300
[29]   Stem cells, cancer, and cancer stem cells [J].
Reya, T ;
Morrison, SJ ;
Clarke, MF ;
Weissman, IL .
NATURE, 2001, 414 (6859) :105-111
[30]   Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications [J].
Roeder, Ingo ;
Horn, Matthias ;
Glauche, Ingmar ;
Hochhaus, Andreas ;
Mueller, Martin C. ;
Loeffler, Markus .
NATURE MEDICINE, 2006, 12 (10) :1181-1184